News
Insight
Currencies
Columns
Events
Search
Recently Searched
Hot Coins
Trending
Daily Must-Read
English
English
简体中文
한국어
日本語
Tiếng Việt
ไทย
Türkçe
Русский
Favorites
Follow
Comments
Creator Platform
Settings
Sign Out
SIGN IN
Welcome Back
Sign in with Twitter
Sign in with Discord
Sign in with Google
Sign in with Apple
Sign in with Email
Click “Sign in” to agree to Cointime’s
Terms of Service
and acknowledge that Cointime’s
Privacy Policy
applies to you.
Join CoinTime
Sign up with Twitter
Sign up with Discord
Sign up with Email
Already have an account?
Sign in
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
{route = 'sent-email'})" />
{route = 'sent-email'})">
Sign in
page.Sign up
All Sign in options
All Sign up options
Check your inbox
Click the link we sent to
to sign in.
Click the link we sent to
to sign up.
OK
Bitcoin
$58,083.01
+2.35%
Ethereum
$2,348.63
+1.00%
BNB
$545.23
+5.96%
Optimism
$1.54
-1.69%
Arbitrum
$0.52
+1.23%
Solana
$134.87
+2.30%
Polygon
$0.38
+0.56%
Cosmos
$4.10
+0.08%
Avalanche
$23.61
+0.07%
Bitcoin
$58,083.01
+2.35%
Ethereum
$2,348.63
+1.00%
BNB
$545.23
+5.96%
Optimism
$1.54
-1.69%
Arbitrum
$0.52
+1.23%
Solana
$134.87
+2.30%
Polygon
$0.38
+0.56%
Cosmos
$4.10
+0.08%
Avalanche
$23.61
+0.07%
Home
/
Ocera Therapeutics
/
investors
Ocera Therapeutics
company
Investors
Number of Lead Investors
Number of Investors
2
20
Ocera Therapeutics is funded by 20 investors.
Sofinnova Investments
and
Greenspring Associates
are the most recent investors.
Investor Name
Lead Investor
Funding Round
Sofinnova Investments
Yes
Series B
Greenspring Associates
-
Post-IPO Debt
Oxford Finance LLC
-
Post-IPO Debt
Silicon Valley Bank
-
Post-IPO Debt
Deerfield Partners
-
Post-IPO Equity
Great Point Partners
-
Post-IPO Equity
InterWest Partners
-
Post-IPO Equity
QVT Financial
-
Post-IPO Equity
RA Capital Management
-
Post-IPO Equity
Three Arch Partners
-
Post-IPO Equity
Venrock
-
Post-IPO Equity
Vivo Capital
-
Post-IPO Equity
AgeChem Venture Fund
-
Series C
CDIB BioScience Ventures
-
Series C
Cross Creek
-
Series C
Domain Associates
-
Series C
FinTech Innovation Lab
-
Series C
Sofinnova Partners
-
Series C
Thomas, McNerney & Partners
-
Series C
Wasatch Advisors
-
Series C
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
Share
{hover = true;if (isWechat) genQrcode($refs.qrcode);}" @mouseleave="hover = false" :style="{'color': platform.color}">
Wechat scan to share
Page Link
Favorite
Favorite